US Edition
LSD Shows Promise for Reducing Anxiety in Drugmaker's Midstage Study
A single supervised dose of lysergic acid diethylamide (LSD) reduced anxiety symptoms in 65% of patients after 12 weeks, supporting further clinical trials.
9 Articles
9 Articles
LSD Shows Promise for Reducing Anxiety in Drugmaker's Midstage Study
WASHINGTON (AP) — LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the U.S. for more than a half century. The results from drugmaker Mindmed tested several doses of LSD in patients with moderate-to-severe […]
LSD reduced anxiety symptoms in several people, according to a mid-stage study published Thursday, paving the way for further testing and possible medical approval of the psychedelic drug, which has been banned in the United States for more than half a century.
Los Angeles Times
Independent EspañolLSD reduced anxiety symptoms in several people, according to a mid-stage study published Thursday, paving the way for further testing and possible medical approval of the psychedelic drug, which has been banned in the United States for more than half a century.
Coverage Details
Bias Distribution
- 43% of the sources lean Left, 43% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
